Pharma Industry, Pharma News, Indian Pharmaceutical Company News, International Pharmaceutical Company News update
 
Need to heal healthcare in 2018

After capping prices of stents, concerns are that the government may now be moving towards expanding the ambit of price caps to other consumables in healthcare.

 
 
 The just concluded year, hurt Indian pharma companies in more ways than one
The court's observation came during a hearing that challenged a Delhi High Court order that had quashed the government ban on technical grounds.
There was a time when the company was staring at bankruptcy and also there was a time it was contemplating huge acquisitions for growth with private equity support.
 
 
On December 7th, Mylan launched 'HepBest', which it called, "the first drug approved in eight years for management of chronic Hepatitis B infection in India." 
The Centre's decision to allow chemists to sell homeopathic medicines could be a significant move. Here's why.
Ahmedabad-based Eris Lifesciences' acquisition of the India brand business of Bengaluru-based Strides Shasun has been in the news.
Advertisement